Y-mAbs Therapeutics Ownership 2024 | Who Owns Y-mAbs Therapeutics Now?
Institutional Ownership
11.46%
Insider Ownership
12.22%
Retail Ownership
76.33%
Institutional Holders
34.00
Y-mAbs Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PARADIGM BIOCAPITAL ADVISORS LP | 8.84% | 1.79% | 3,870,594 | 1,636,984 | 73.29% | 46,756,776 | Jun 30, 2024 |
| BLACKROCK INC. | 6.71% | 0.00% | 2,938,718 | 81,461 | 2.85% | 35,499,713 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 5.01% | 1.38% | 2,194,278 | - | - | 26,506,878 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.47% | 0.00% | 1,957,339 | -112,178 | -5.42% | 23,644,655 | Jun 30, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 4.18% | 0.13% | 1,831,000 | - | - | 22,118,480 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 3.31% | 1.01% | 1,450,000 | 1,450,000 | 100.00% | 17,516,000 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 2.12% | 0.01% | 926,457 | -141,702 | -13.27% | 11,191,601 | Jun 30, 2024 |
| STATE STREET CORP | 1.84% | 0.00% | 804,612 | 53,539 | 7.13% | 9,719,713,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.75% | 0.00% | 765,643 | 22,894 | 3.08% | 9,250,856 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 1.51% | 0.01% | 659,672 | -86,429 | -11.58% | 7,968,838 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 1.48% | 0.69% | 647,982 | 77,000 | 13.49% | 7,827,623 | Jun 30, 2024 |
| CALIGAN PARTNERS LP | 1.33% | 1.64% | 582,078 | -5,198 | -0.89% | 7,031,502 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.11% | 0.00% | 484,431 | 65,732 | 15.70% | 5,852,656 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.84% | 0.11% | 369,360 | 22,849 | 6.59% | 4,461,869 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.82% | 0.01% | 358,945 | -1,168,155 | -76.50% | 4,336,056 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.80% | 0.00% | 349,784 | 67,233 | 23.80% | 4,225,391 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.74% | 0.01% | 323,175 | -279,139 | -46.34% | 3,902,000 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.73% | 0.00% | 317,805 | -3,910 | -1.22% | 3,839,084,000 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.58% | 0.00% | 255,595 | 5,370 | 2.15% | 3,087,588 | Jun 30, 2024 |
| MORGAN STANLEY | 0.46% | 0.00% | 203,140 | 15,043 | 8.00% | 2,453,932 | Jun 30, 2024 |
Y-mAbs Therapeutics's largest institutional shareholder is PARADIGM BIOCAPITAL ADVISORS LP, holding 8.84% of the company's total share outstanding, currently valued at $46.76M. The top 10 institutional shareholders own together 39.74% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PARADIGM BIOCAPITAL ADVISORS LP | 8.84% | 1.79% | 3,870,594 | 1,636,984 | 73.29% | 46,756,776 | Jun 30, 2024 |
| CALIGAN PARTNERS LP | 1.33% | 1.64% | 582,078 | -5,198 | -0.89% | 7,031,502 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 5.01% | 1.38% | 2,194,278 | - | - | 26,506,878 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 3.31% | 1.01% | 1,450,000 | 1,450,000 | 100.00% | 17,516,000 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 1.48% | 0.69% | 647,982 | 77,000 | 13.49% | 7,827,623 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.06% | 0.16% | 27,332 | 27,332 | 100.00% | 330,171 | Jun 30, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 4.18% | 0.13% | 1,831,000 | - | - | 22,118,480 | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | 0.01% | 0.11% | 6,152 | 6,152 | 100.00% | 74,316 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.84% | 0.11% | 369,360 | 22,849 | 6.59% | 4,461,869 | Jun 30, 2024 |
| RICE HALL JAMES & ASSOCIATES, LLC | 0.20% | 0.07% | 89,735 | 3,589 | 4.17% | 1,083,999 | Jun 30, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | 0.14% | 0.06% | 62,046 | -14,394 | -18.83% | 749,516 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.05% | 0.05% | 23,647 | 23,647 | 100.00% | 285,656 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.06% | 0.03% | 24,621 | 24,621 | 100.00% | 297,422 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.17% | 0.02% | 76,000 | 10,400 | 15.85% | 918,080 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.74% | 0.01% | 323,175 | -279,139 | -46.34% | 3,902,000 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.82% | 0.01% | 358,945 | -1,168,155 | -76.50% | 4,336,056 | Jun 30, 2024 |
| SAPIENT CAPITAL LLC | 0.10% | 0.01% | 43,700 | - | - | 527,896 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 2.12% | 0.01% | 926,457 | -141,702 | -13.27% | 11,191,601 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 1.51% | 0.01% | 659,672 | -86,429 | -11.58% | 7,968,838 | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 0.40% | 0.01% | 176,055 | -26,019 | -12.88% | 2,126,744 | Jun 30, 2024 |
The largest Y-mAbs Therapeutics shareholder by % of total assets is PARADIGM BIOCAPITAL ADVISORS LP. The company owns 3.87M shares of Y-mAbs Therapeutics (YMAB), representing 1.79% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PARADIGM BIOCAPITAL ADVISORS LP | 8.84% | 1.79% | 3,870,594 | 1,636,984 | 73.29% | 46,756,776 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 3.31% | 1.01% | 1,450,000 | 1,450,000 | 100.00% | 17,516,000 | Jun 30, 2024 |
| BLACKROCK INC. | 6.71% | 0.00% | 2,938,718 | 81,461 | 2.85% | 35,499,713 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 1.48% | 0.69% | 647,982 | 77,000 | 13.49% | 7,827,623 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.29% | 0.00% | 126,389 | 74,452 | 143.35% | 1,526,779 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.80% | 0.00% | 349,784 | 67,233 | 23.80% | 4,225,391 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.11% | 0.00% | 484,431 | 65,732 | 15.70% | 5,852,656 | Jun 30, 2024 |
| SWISS NATIONAL BANK | 0.14% | 0.00% | 60,300 | 60,300 | 100.00% | 728,424,000 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.13% | 0.00% | 58,299 | 58,299 | 100.00% | 704,252 | Jun 30, 2024 |
| STATE STREET CORP | 1.84% | 0.00% | 804,612 | 53,539 | 7.13% | 9,719,713,000 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.10% | 0.00% | 43,973 | 43,973 | 100.00% | 531,194 | Jun 30, 2024 |
| ALPS ADVISORS INC | 0.08% | 0.00% | 34,224 | 34,224 | 100.00% | 413,426 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 0.15% | 0.00% | 66,977 | 33,996 | 103.08% | 809,081 | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | 0.08% | 0.00% | 36,581 | 33,270 | 1004.83% | 441,899 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.10% | - | 44,683 | 31,546 | 240.13% | 539,770 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.06% | 0.16% | 27,332 | 27,332 | 100.00% | 330,171 | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0.07% | 0.00% | 30,449 | 26,749 | 722.95% | 367,824 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.06% | 0.03% | 24,621 | 24,621 | 100.00% | 297,422 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.05% | 0.05% | 23,647 | 23,647 | 100.00% | 285,656 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.75% | 0.00% | 765,643 | 22,894 | 3.08% | 9,250,856 | Jun 30, 2024 |
As of Jun 30 2024, Y-mAbs Therapeutics's largest institutional buyer is PARADIGM BIOCAPITAL ADVISORS LP. The company purchased 1.64M stocks of YMAB, valued at $46.76M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| POINT72 ASSET MANAGEMENT, L.P. | 0.82% | 0.01% | 358,945 | -1,168,155 | -76.50% | 4,336,056 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.74% | 0.01% | 323,175 | -279,139 | -46.34% | 3,902,000 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.32% | 0.00% | 138,739 | -226,797 | -62.05% | 1,675,967 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.26% | 0.00% | 112,483 | -155,247 | -57.99% | 1,358,795 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 2.12% | 0.01% | 926,457 | -141,702 | -13.27% | 11,191,601 | Jun 30, 2024 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | - | - | - | -127,551 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.47% | 0.00% | 1,957,339 | -112,178 | -5.42% | 23,644,655 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 1.51% | 0.01% | 659,672 | -86,429 | -11.58% | 7,968,838 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.02% | 0.00% | 6,597 | -71,189 | -91.52% | 79,695 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.15% | 0.00% | 64,637 | -50,663 | -43.94% | 780,815 | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | - | - | - | -45,799 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.14% | 0.00% | 61,316 | -42,986 | -41.21% | 740,697 | Jun 30, 2024 |
| BOSTON PARTNERS | - | - | - | -34,165 | -100.00% | - | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 0.40% | 0.01% | 176,055 | -26,019 | -12.88% | 2,126,744 | Jun 30, 2024 |
| CAXTON ASSOCIATES LP | - | - | - | -18,807 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | 0.04% | 0.00% | 19,004 | -18,543 | -49.39% | 229,568 | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -18,132 | -100.00% | - | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | - | - | - | -16,588 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -16,216 | -100.00% | - | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.05% | 0.00% | 21,926 | -15,915 | -42.06% | 264,866 | Jun 30, 2024 |
As of Jun 30 2024, Y-mAbs Therapeutics's biggest institutional seller is POINT72 ASSET MANAGEMENT, L.P.. The company sold -1.17M shares of YMAB, valued at $4.34M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CORMORANT ASSET MANAGEMENT, LP | 3.31% | 1.01% | 1,450,000 | 1,450,000 | 100.00% | 17,516,000 | Jun 30, 2024 |
| SWISS NATIONAL BANK | 0.14% | 0.00% | 60,300 | 60,300 | 100.00% | 728,424,000 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.13% | 0.00% | 58,299 | 58,299 | 100.00% | 704,252 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.10% | 0.00% | 43,973 | 43,973 | 100.00% | 531,194 | Jun 30, 2024 |
| ALPS ADVISORS INC | 0.08% | 0.00% | 34,224 | 34,224 | 100.00% | 413,426 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.06% | 0.16% | 27,332 | 27,332 | 100.00% | 330,171 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.06% | 0.03% | 24,621 | 24,621 | 100.00% | 297,422 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.05% | 0.05% | 23,647 | 23,647 | 100.00% | 285,656 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 19,787 | 19,787 | 100.00% | 239,027 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 17,897 | 17,897 | 100.00% | 216,196 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 0.04% | 0.00% | 16,300 | 16,300 | 100.00% | 196,741 | Jun 30, 2024 |
| GREAT WEST LIFE ASSURANCE CO /CAN/ | 0.01% | 0.00% | 3,048 | 3,048 | 100.00% | 37,000 | Jun 30, 2024 |
| SIGNATUREFD, LLC | 0.00% | - | 64 | 64 | 100.00% | 773 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 30 | 30 | 100.00% | 362 | Jun 30, 2024 |
| QUEST PARTNERS LLC | - | - | 1 | 1 | 100.00% | 12 | Jun 30, 2024 |
Y-mAbs Therapeutics's largest new institutional shareholder by number of shares is CORMORANT ASSET MANAGEMENT, LP, purchased 1.45M shares, valued at $17.52M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| LOS ANGELES CAPITAL MANAGEMENT LLC | - | - | - | -127,551 | -100.00% | - | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | - | - | - | -45,799 | -100.00% | - | Jun 30, 2024 |
| BOSTON PARTNERS | - | - | - | -34,165 | -100.00% | - | Jun 30, 2024 |
| CAXTON ASSOCIATES LP | - | - | - | -18,807 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -18,132 | -100.00% | - | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | - | - | - | -16,588 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -16,216 | -100.00% | - | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | - | - | - | -13,729 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -11,963 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -6,019 | -100.00% | - | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -4,532 | -100.00% | - | Jun 30, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | - | - | - | -3,300 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -2,055 | -100.00% | - | Jun 30, 2024 |
| TUCKER ASSET MANAGEMENT LLC | - | - | - | -1,200 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -8 | -100.00% | - | Jun 30, 2024 |
Y-mAbs Therapeutics's largest sold out institutional shareholder by shares sold is LOS ANGELES CAPITAL MANAGEMENT LLC, sold -0.13M shares, valued at -, as of undefined.
Y-mAbs Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| HARTFORD HLS SERIES FUND II INC | 0.69% | 169,127 | - | - | Dec 31, 2023 |
| TEKLA HEALTHCARE INVESTORS | 0.16% | 135,765 | - | - | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.13% | 62,055 | - | - | Mar 31, 2024 |
| VANGUARD EXPLORER FUND | 0.13% | 1,621,623 | - | - | Jan 31, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.10% | 330,836 | - | - | Mar 31, 2024 |
| PUTNAM GLOBAL HEALTH CARE FUND | 0.08% | 125,186 | - | - | Feb 29, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.05% | 25,975 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.04% | 939 | - | - | Dec 31, 2023 |
| T. Rowe Price New Horizons Fund, Inc. | 0.03% | 145,207 | - | - | Mar 31, 2024 |
| IndexIQ ETF Trust | 0.03% | 65,365 | -4,005 | -5.77% | Jan 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.03% | 65,600 | -30,000 | -31.38% | Mar 28, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.03% | 1,740,751 | - | - | Feb 29, 2024 |
| AB CAP FUND, INC. | 0.03% | 869,352 | - | - | Jan 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.02% | 194,803 | - | - | Jan 31, 2024 |
| Federated Hermes MDT Series | 0.02% | 44,474 | - | - | Jan 31, 2024 |
| ETFis Series Trust I | 0.01% | 20,612 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 63,965 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 5,581 | - | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 29,763 | - | - | Feb 29, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.01% | 15,065 | - | - | Mar 31, 2024 |
| Bernstein Fund Inc | 0.01% | 54,259 | - | - | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.01% | 21,799 | -6,825 | -23.84% | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 959 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,623,095 | -470,587 | -22.48% | Mar 31, 2024 |
| Nushares ETF Trust | 0.00% | 27,552 | - | - | Jan 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.00% | 32,751 | - | - | Mar 28, 2024 |
| AB VARIABLE PRODUCTS SERIES FUND, INC. | 0.00% | 15,744 | - | - | Mar 31, 2024 |
| ALPS ETF Trust | 0.00% | 42,317 | - | - | Feb 29, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 21,928 | - | - | Aug 31, 2023 |
| JNL VARIABLE FUND LLC | 0.00% | 15,199 | - | - | Mar 31, 2020 |
| SCHWAB CAPITAL TRUST | 0.00% | 99,319 | -4,727 | -4.54% | Jan 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 62,720 | - | - | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 103,404 | - | - | Mar 31, 2024 |
| North Square Investments Trust | 0.00% | 16,280 | - | - | Jan 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 15,630 | 493 | 3.26% | Mar 28, 2024 |
| ETF Series Solutions | 0.00% | 33,055 | 5,296 | 19.08% | Feb 29, 2024 |
| MML SERIES INVESTMENT FUND | 0.00% | 14,253 | - | - | Dec 31, 2023 |
| HARTFORD SERIES FUND INC | 0.00% | 60,027 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 290,001 | 10,620 | 3.80% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 3,701 | 1,056 | 39.92% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 14,180 | 153 | 1.09% | Mar 31, 2024 |
| Managed Portfolio Series | 0.00% | 24,560 | - | - | Jan 31, 2024 |
| MFS VARIABLE INSURANCE TRUST III | 0.00% | 16,131 | -655 | -3.90% | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 79,690 | - | - | Jan 31, 2024 |
| NORTHWESTERN MUTUAL SERIES FUND INC | 0.00% | 102,833 | - | - | Mar 31, 2024 |
| GPS Funds I | 0.00% | 4,799 | - | - | Mar 31, 2024 |
| Lattice Strategies Trust | 0.00% | 1,219 | 1,219 | - | Mar 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.00% | 18,518 | -267,792 | -93.53% | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 9,130 | -1,114 | -10.87% | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 109,514 | - | - | Jan 31, 2024 |
| NEW COVENANT FUNDS | 0.00% | 3,117 | - | - | Dec 31, 2023 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 21,582 | -1,583 | -6.83% | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 12,959 | -8,969 | -40.90% | Mar 31, 2024 |
| HARTFORD MUTUAL FUNDS II INC | 0.00% | 109,120 | - | - | Jan 31, 2024 |
| ARTISAN PARTNERS FUNDS INC | 0.00% | 1,017,009 | - | - | Mar 31, 2024 |
| Global X Funds | 0.00% | 25,001 | - | - | Jan 31, 2024 |
| PUTNAM FUNDS TRUST | 0.00% | 108,000 | - | - | Jan 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 119,150 | 608 | 0.51% | Feb 29, 2024 |
| SunAmerica Specialty Series | 0.00% | 247 | - | - | Apr 30, 2021 |
| PRUDENTIAL INVESTMENT PORTFOLIOS, INC. | 0.00% | 4,300 | - | - | Mar 28, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 2,100 | - | - | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 14,136 | - | - | Mar 31, 2024 |
| Meeder Funds | 0.00% | 1,867 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 12,190 | -3,415 | -21.88% | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 47,298 | -24,108 | -33.76% | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,660 | -462 | -21.77% | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 33,046 | 9,814 | 42.24% | Feb 29, 2024 |
| AMG FUNDS III | 0.00% | 1,451 | - | - | Mar 28, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 152,377 | 5,089 | 3.46% | Feb 29, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 4,746 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 616 | - | - | Mar 31, 2024 |
| RBB FUND, INC. | 0.00% | 19,929 | - | - | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 13,200 | 1,100 | 9.09% | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 26,911 | -917 | -3.30% | Mar 28, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 190,722 | 45,347 | 31.19% | Jan 31, 2024 |
| LOOMIS SAYLES FUNDS II | 0.00% | 466,773 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 21,705 | 8,029 | 58.71% | Jan 31, 2024 |
| Trust for Advised Portfolios | 0.00% | 2,952 | - | - | Dec 31, 2023 |
| PUTNAM VARIABLE TRUST | 0.00% | 5,115 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 59,713 | 18,473 | 44.79% | Jan 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 143,055 | -124,580 | -46.55% | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 2,342 | 98 | 4.37% | Mar 31, 2024 |
| OLD WESTBURY FUNDS INC | 0.00% | 13,484 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 124,439 | -5,267 | -4.06% | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 1,623,982 | -54,529 | -3.25% | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 6,352 | - | - | Feb 29, 2024 |
| FundVantage Trust | 0.00% | 1,354 | - | - | Mar 28, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 8,483 | -2,568 | -23.24% | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 165,907 | 19,710 | 13.48% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 336 | - | - | Dec 31, 2023 |
| JPMORGAN INSURANCE TRUST | 0.00% | 900 | - | - | Mar 31, 2023 |
| PACE SELECT ADVISORS TRUST | 0.00% | 19,058 | - | - | Jan 31, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 169,440 | 27,840 | 19.66% | Dec 31, 2023 |
| FLEXSHARES TRUST | 0.00% | 4,278 | - | - | Jan 31, 2024 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 802 | - | - | Mar 31, 2024 |
| VALIC Co I | 0.00% | 14,119 | -57 | -0.40% | Feb 29, 2024 |
| GOLDMAN SACHS TRUST | 0.00% | 161,416 | 4,199 | 2.67% | Jan 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 129,859 | - | - | Jan 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,200 | - | - | Mar 28, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 166 | - | - | Dec 31, 2023 |
Y-mAbs Therapeutics's largest mutual fund holder by % of total assets is "HARTFORD HLS SERIES FUND II INC", owning 169.13K shares, compromising 0.69% of its total assets.
Y-mAbs Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 34 | -65.66% |
| 31 Mar, 24 | 99 | 6.45% |
| 31 Dec, 23 | 93 | -5.10% |
| 30 Sep, 23 | 98 | 1.03% |
| 30 Jun, 23 | 97 | 12.79% |
| 31 Mar, 23 | 86 | -6.52% |
| 31 Dec, 22 | 92 | -9.80% |
| 30 Sep, 22 | 102 | 8.51% |
| 30 Jun, 22 | 94 | 4.44% |
| 31 Mar, 22 | 90 | -4.26% |
| 31 Dec, 21 | 94 | -4.08% |
| 30 Sep, 21 | 98 | -1.01% |
| 30 Jun, 21 | 99 | -16.10% |
| 31 Mar, 21 | 118 | 4.42% |
| 31 Dec, 20 | 113 | 6.60% |
| 30 Sep, 20 | 106 | -2.75% |
| 30 Jun, 20 | 109 | 36.25% |
| 31 Mar, 20 | 80 | -1.23% |
| 31 Dec, 19 | 81 | 24.62% |
| 30 Sep, 19 | 65 | 10.17% |
| 30 Jun, 19 | 59 | 34.09% |
| 31 Mar, 19 | 44 | 4.76% |
| 31 Dec, 18 | 42 | 10.53% |
| 30 Sep, 18 | 38 | - |
As of 30 Jun 24, 34 institutions are holding Y-mAbs Therapeutics's shares, representing a decrease of -65.66% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 5,015,244 | -78.20% |
| 31 Mar, 24 | 23,007,884 | 13.95% |
| 31 Dec, 23 | 20,191,085 | 2.81% |
| 30 Sep, 23 | 19,640,023 | -0.74% |
| 30 Jun, 23 | 19,785,495 | 4.10% |
| 31 Mar, 23 | 19,006,537 | -1.62% |
| 31 Dec, 22 | 19,319,778 | -18.00% |
| 30 Sep, 22 | 23,559,613 | -4.86% |
| 30 Jun, 22 | 24,763,575 | -2.11% |
| 31 Mar, 22 | 25,296,943 | -1.67% |
| 31 Dec, 21 | 25,725,752 | -1.94% |
| 30 Sep, 21 | 26,235,220 | 0.38% |
| 30 Jun, 21 | 26,135,469 | -1.40% |
| 31 Mar, 21 | 26,505,868 | 18.00% |
| 31 Dec, 20 | 22,461,839 | 4.77% |
| 30 Sep, 20 | 21,438,912 | 0.73% |
| 30 Jun, 20 | 21,284,338 | 6.05% |
| 31 Mar, 20 | 20,069,809 | 3.43% |
| 31 Dec, 19 | 19,404,465 | 47.68% |
| 30 Sep, 19 | 13,139,739 | 19.75% |
| 30 Jun, 19 | 10,972,460 | 29.39% |
| 31 Mar, 19 | 8,480,260 | -2.37% |
| 31 Dec, 18 | 8,686,033 | 12.32% |
| 30 Sep, 18 | 7,733,371 | - |
Y-mAbs Therapeutics (YMAB) has 5.02M shares outstanding as of 30 Jun 24, down -78.20% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 11.46% | 0.41% |
| 31 Mar, 24 | 52.74% | 2.46% |
| 31 Dec, 23 | 46.29% | 2.29% |
| 30 Sep, 23 | 44.98% | 2.19% |
| 30 Jun, 23 | 45.31% | 2.39% |
| 31 Mar, 23 | 43.52% | 2.23% |
| 31 Dec, 22 | 44.21% | 1.52% |
| 30 Sep, 22 | 53.89% | 1.68% |
| 30 Jun, 22 | 56.64% | 1.69% |
| 31 Mar, 22 | 57.88% | 1.63% |
| 31 Dec, 21 | 59.58% | 1.65% |
| 30 Sep, 21 | 60.17% | 1.67% |
| 30 Jun, 21 | 59.99% | 1.50% |
| 31 Mar, 21 | 63.30% | 2.02% |
| 31 Dec, 20 | 55.99% | 1.97% |
| 30 Sep, 20 | 53.35% | 1.88% |
| 30 Jun, 20 | 53.25% | 2.09% |
| 31 Mar, 20 | 50.49% | 2.12% |
| 31 Dec, 19 | 48.81% | 3.34% |
| 30 Sep, 19 | 38.23% | 3.71% |
| 30 Jun, 19 | 32.09% | 5.22% |
| 31 Mar, 19 | 24.80% | 2.72% |
| 31 Dec, 18 | 30.19% | 3.77% |
| 30 Sep, 18 | 28.30% | - |
As of 30 Jun 24, Y-mAbs Therapeutics is held by 11.46% institutional shareholders, representing a 0.41% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 17 | -62.22% |
| 31 Mar, 24 | 45 | -4.26% |
| 31 Dec, 23 | 47 | 20.51% |
| 30 Sep, 23 | 39 | -26.42% |
| 30 Jun, 23 | 53 | 12.77% |
| 31 Mar, 23 | 47 | 6.82% |
| 31 Dec, 22 | 44 | 4.76% |
| 30 Sep, 22 | 42 | -16.00% |
| 30 Jun, 22 | 50 | 16.28% |
| 31 Mar, 22 | 43 | -17.31% |
| 31 Dec, 21 | 52 | 4.00% |
| 30 Sep, 21 | 50 | -15.25% |
| 30 Jun, 21 | 59 | -20.27% |
| 31 Mar, 21 | 74 | 19.35% |
| 31 Dec, 20 | 62 | 19.23% |
| 30 Sep, 20 | 52 | -28.77% |
| 30 Jun, 20 | 73 | 87.18% |
| 31 Mar, 20 | 39 | -40.91% |
| 31 Dec, 19 | 66 | 69.23% |
| 30 Sep, 19 | 39 | -13.33% |
| 30 Jun, 19 | 45 | 136.84% |
| 31 Mar, 19 | 19 | -29.63% |
| 31 Dec, 18 | 27 | -28.95% |
| 30 Sep, 18 | 38 | - |
17 institutional shareholders have increased their position in YMAB stock as of 30 Jun 24 compared to 45 in the previous quarter (a -62.22% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 10 | -76.74% |
| 31 Mar, 24 | 43 | 38.71% |
| 31 Dec, 23 | 31 | -16.22% |
| 30 Sep, 23 | 37 | 19.35% |
| 30 Jun, 23 | 31 | 29.17% |
| 31 Mar, 23 | 24 | -27.27% |
| 31 Dec, 22 | 33 | -5.71% |
| 30 Sep, 22 | 35 | 40.00% |
| 30 Jun, 22 | 25 | -19.35% |
| 31 Mar, 22 | 31 | 10.71% |
| 31 Dec, 21 | 28 | -9.68% |
| 30 Sep, 21 | 31 | 47.62% |
| 30 Jun, 21 | 21 | -34.38% |
| 31 Mar, 21 | 32 | -5.88% |
| 31 Dec, 20 | 34 | -10.53% |
| 30 Sep, 20 | 38 | 31.03% |
| 30 Jun, 20 | 29 | -6.45% |
| 31 Mar, 20 | 31 | 244.44% |
| 31 Dec, 19 | 9 | -35.71% |
| 30 Sep, 19 | 14 | 55.56% |
| 30 Jun, 19 | 9 | -35.71% |
| 31 Mar, 19 | 14 | 40.00% |
| 31 Dec, 18 | 10 | - |
| 30 Sep, 18 | - | - |
10 institutional shareholders have reduced their position in YMAB stock as of 30 Jun 24 compared to 43 in the previous quarter (a -76.74% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 34 | -65.66% | 5,015,244 | -78.20% | 11.46% | 0.41% | 17 | -62.22% | 10 | -76.74% |
| 31 Mar, 24 | 99 | 6.45% | 23,007,884 | 13.95% | 52.74% | 2.46% | 45 | -4.26% | 43 | 38.71% |
| 31 Dec, 23 | 93 | -5.10% | 20,191,085 | 2.81% | 46.29% | 2.29% | 47 | 20.51% | 31 | -16.22% |
| 30 Sep, 23 | 98 | 1.03% | 19,640,023 | -0.74% | 44.98% | 2.19% | 39 | -26.42% | 37 | 19.35% |
| 30 Jun, 23 | 97 | 12.79% | 19,785,495 | 4.10% | 45.31% | 2.39% | 53 | 12.77% | 31 | 29.17% |
| 31 Mar, 23 | 86 | -6.52% | 19,006,537 | -1.62% | 43.52% | 2.23% | 47 | 6.82% | 24 | -27.27% |
| 31 Dec, 22 | 92 | -9.80% | 19,319,778 | -18.00% | 44.21% | 1.52% | 44 | 4.76% | 33 | -5.71% |
| 30 Sep, 22 | 102 | 8.51% | 23,559,613 | -4.86% | 53.89% | 1.68% | 42 | -16.00% | 35 | 40.00% |
| 30 Jun, 22 | 94 | 4.44% | 24,763,575 | -2.11% | 56.64% | 1.69% | 50 | 16.28% | 25 | -19.35% |
| 31 Mar, 22 | 90 | -4.26% | 25,296,943 | -1.67% | 57.88% | 1.63% | 43 | -17.31% | 31 | 10.71% |
| 31 Dec, 21 | 94 | -4.08% | 25,725,752 | -1.94% | 59.58% | 1.65% | 52 | 4.00% | 28 | -9.68% |
| 30 Sep, 21 | 98 | -1.01% | 26,235,220 | 0.38% | 60.17% | 1.67% | 50 | -15.25% | 31 | 47.62% |
| 30 Jun, 21 | 99 | -16.10% | 26,135,469 | -1.40% | 59.99% | 1.50% | 59 | -20.27% | 21 | -34.38% |
| 31 Mar, 21 | 118 | 4.42% | 26,505,868 | 18.00% | 63.30% | 2.02% | 74 | 19.35% | 32 | -5.88% |
| 31 Dec, 20 | 113 | 6.60% | 22,461,839 | 4.77% | 55.99% | 1.97% | 62 | 19.23% | 34 | -10.53% |
| 30 Sep, 20 | 106 | -2.75% | 21,438,912 | 0.73% | 53.35% | 1.88% | 52 | -28.77% | 38 | 31.03% |
| 30 Jun, 20 | 109 | 36.25% | 21,284,338 | 6.05% | 53.25% | 2.09% | 73 | 87.18% | 29 | -6.45% |
| 31 Mar, 20 | 80 | -1.23% | 20,069,809 | 3.43% | 50.49% | 2.12% | 39 | -40.91% | 31 | 244.44% |
| 31 Dec, 19 | 81 | 24.62% | 19,404,465 | 47.68% | 48.81% | 3.34% | 66 | 69.23% | 9 | -35.71% |
| 30 Sep, 19 | 65 | 10.17% | 13,139,739 | 19.75% | 38.23% | 3.71% | 39 | -13.33% | 14 | 55.56% |
| 30 Jun, 19 | 59 | 34.09% | 10,972,460 | 29.39% | 32.09% | 5.22% | 45 | 136.84% | 9 | -35.71% |
| 31 Mar, 19 | 44 | 4.76% | 8,480,260 | -2.37% | 24.80% | 2.72% | 19 | -29.63% | 14 | 40.00% |
| 31 Dec, 18 | 42 | 10.53% | 8,686,033 | 12.32% | 30.19% | 3.77% | 27 | -28.95% | 10 | - |
| 30 Sep, 18 | 38 | - | 7,733,371 | - | 28.30% | - | 38 | - | - | - |
Y-mAbs Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Y-mAbs Therapeutics's stock was made by Ber Gerard on Jun 11 2024, selling 722 shares at $12.00 per share (valued at $8.66K).
Y-mAbs Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 2 | - | - |
| Q2 2024 | 14 | 9 | 155.56% |
| Q1 2024 | 19 | 3 | 633.33% |
| Q4 2023 | 17 | 6 | 283.33% |
| Q2 2023 | 14 | - | - |
| Q1 2023 | 19 | - | - |
| Q4 2022 | 1 | - | - |
| Q3 2022 | 12 | - | - |
| Q2 2022 | 10 | - | - |
| Q1 2022 | 2 | 20 | 10.00% |
| Q4 2021 | 10 | 20 | 50.00% |
| Q3 2021 | 2 | 17 | 11.76% |
| Q2 2021 | 9 | 31 | 29.03% |
| Q1 2021 | 8 | 21 | 38.10% |
| Q4 2020 | 15 | 20 | 75.00% |
| Q3 2020 | 3 | 14 | 21.43% |
| Q2 2020 | 9 | 18 | 50.00% |
| Q1 2020 | 6 | 15 | 40.00% |
| Q4 2019 | 5 | 9 | 55.56% |
| Q3 2019 | - | 20 | - |
2 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Y-mAbs Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | - | 7 | - |
| Q1 2024 | - | 3 | - |
| Q4 2023 | 14 | 5 | 280.00% |
| Q2 2023 | 2 | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | 1 | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | 18 | - |
| Q4 2021 | - | 18 | - |
| Q3 2021 | 1 | 16 | 6.25% |
| Q2 2021 | - | 28 | - |
| Q1 2021 | - | 13 | - |
| Q4 2020 | 2 | 14 | 14.29% |
| Q3 2020 | - | 11 | - |
| Q2 2020 | - | 18 | - |
| Q1 2020 | 1 | 6 | 16.67% |
| Q4 2019 | 1 | 6 | 16.67% |
| Q3 2019 | - | 18 | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Y-mAbs Therapeutics's stocks.
Y-mAbs Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| VECT | VectivBio Holding AG |
| ZNTL | Zentalis Pharmaceuticals, Inc. |
| RVMD | Revolution Medicines, Inc. Warrant |
| MRUS | Merus N.V. |
| LRMR | Larimar Therapeutics, Inc. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| ERAS | Erasca, Inc. |
| BLUE | bluebird bio, Inc. |
| TVTX | Travere Therapeutics, Inc. |
| STRO | Sutro Biopharma, Inc. |
| GBIO | Generation Bio Co. |
| ARQT | Arcutis Biotherapeutics, Inc. |
| BDTX | Black Diamond Therapeutics, Inc. |
| BCEL | Atreca, Inc. |
| SNDX | Syndax Pharmaceuticals, Inc. |
| KRON | Kronos Bio, Inc. |
| PASG | Passage Bio, Inc. |
| CCCC | C4 Therapeutics, Inc. |
| MRSN | Mersana Therapeutics, Inc. |
| PCVX | Vaxcyte, Inc. |
| MIRM | Mirum Pharmaceuticals, Inc. |
YMAB Ownership FAQ
Who Owns Y-mAbs Therapeutics?
Y-mAbs Therapeutics is owned by institutional shareholders (11.46%), insiders (12.22%), and public (76.33%). The largest institutional shareholder of Y-mAbs Therapeutics is PARADIGM BIOCAPITAL ADVISORS LP (8.84% of total shares) and the top mutual fund owner is HARTFORD HLS SERIES FUND II INC (0.69% of total shares).
Who are the major institutional shareholders of Y-mAbs Therapeutics?
Y-mAbs Therapeutics's major institutional shareholders are PARADIGM BIOCAPITAL ADVISORS LP, BLACKROCK INC., SOFINNOVA INVESTMENTS, INC., VANGUARD GROUP INC, and POLAR CAPITAL HOLDINGS PLC. The top five shareholders own together 29.22% of the company's share outstanding.
How many Y-mAbs Therapeutics shareholders are there?
As of Jun 2024, there are 34 institutional shareholders of Y-mAbs Therapeutics.
What percentage of Y-mAbs Therapeutics is owned by PARADIGM BIOCAPITAL ADVISORS LP?
PARADIGM BIOCAPITAL ADVISORS LP owns 3.87M shares of Y-mAbs Therapeutics, representing 8.84% of the company's total shares outstanding, valued at $46.76M (as of Jun 2024).
What percentage of Y-mAbs Therapeutics is owned by BLACKROCK INC?
As of Jun 2024, BLACKROCK INC holds 2.94M shares of Y-mAbs Therapeutics (YMAB), compromising 6.71% of the company, valued at $35.5M.
What percentage of Y-mAbs Therapeutics is owned by SOFINNOVA INVESTMENTS, INC?
SOFINNOVA INVESTMENTS, INC is the third largest holder of Y-mAbs Therapeutics. The company owns 2.19M of the company's shares outstanding (worth $26.51M).